 HEIDELBERG, Germany, June 22, 2021 GLOBE NEWSWIRE -- Affimed N.V. Nasdaq: AFMD, a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it will release first quarter 2021 results on Thursday, July 1, 2021, and host a conference call at 8:30 a.m. EDT to discuss financial results and recent corporate developments. 